Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists by Tran, R.T. et al.
87
clinical
J R Coll Physicians Edinb 2016 46: 87–92
http://dx.doi.org/10.4997/JRCPE.2016.204
© 2016 Royal College of Physicians of Edinburgh
INTRODUCTION
Atrial fibrillation (AF) is a risk factor for ischaemic 
stroke, independent of whether the condition is 
permanent, persistent or paroxysmal.1 The diagnosis 
requires consideration of long-term oral anticoagulant 
use as stroke thromboprophylaxis. For an 
electrocardiographic diagnosis of AF on ambulatory 
monitoring, the European Society of Cardiology advises 
that a recording showing typical features of AF lasts ≥ 30 
seconds.2 The clinical significance of shorter runs of 
atrial tachyarrhythmia (i.e. those lasting < 30 seconds), 
which electrocardiographically resemble AF, is unknown.
There is increasing interest in asymptomatic AF and 
stroke. These ‘occult’3 or ‘silent’4 AF episodes are thought 
to confer a significant stroke risk, but may have gone 
undetected by conventional investigation. A recent 
review concluded that silent AF is found in approximately 
30% of patients with cryptogenic stroke.4 However, in 
line with guidelines, the majority of studies included 
required a recording ≥ 30 seconds for a diagnosis of AF. 
A major factor in the selection of this threshold may be 
the use of algorithms for automated detection of AF that 
demand a certain number of R-R intervals to assess 
variability with sufficient confidence to trigger the 
diagnosis, rather than on clinical grounds alone. 
There is no evidence to suggest that a run of AF lasting 
> 30 seconds is more important than a shorter episode. 
Binici et al. found that the risk of death or stroke in 
previously healthy individuals was significantly higher in 
those with ‘excessive supraventricular ectopic activity’.5 
Furthermore, Kochhäuser et al. demonstrated that 
numerous runs of supraventricular premature beats are 
predictive of future AF in patients with cryptogenic 
stroke.6 However, no consensus exists as to how such 
ambulatory ECG findings should be investigated, 
diagnosed and managed.
This clinical dilemma was highlighted in a recent survey 
of stroke physicians and cardiologists within the UK, 
which explored current management of patients with 
short runs of atrial arrhythmia suggestive of AF on 
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ambulatory ECG monitoring.7 However, the findings 
may be limited and relevant to the standard of 
practice in the UK only. In this study, we aimed to 
evaluate and compare clinical practice relating to the 
short runs of atrial arrhythmias and the perception of 
stroke risk among stroke physicians and cardiologists 
across Europe.
MeTHODS
Survey questionnaire
A survey questionnaire was created using Survey 
Monkey (www.surveymonkey.com). This comprised 
12 questions: three to define basic demographic data 
for respondents; four to determine each respondent’s 
diagnostic criteria for AF; two to establish their 
current practice regarding the investigation of possible 
AF following ischaemic stroke; and three to investigate 
specific factors that would influence a physician’s 
decision to start oral anticoagulant treatment 
(Appendix 1, available with the online version of this 
paper). All questions required an answer to complete 
the survey, with space for optional additional 
comments at the end. The aim was not to assess 
physicians’ knowledge of clinical guidelines, but rather 
to elicit what clinicians do in their daily practice. For 
the purposes of the survey, electrocardiographic 
findings suggestive of AF were defined as ‘atrial 
arrhythmia without p waves and with irregular 
ventricular response’.
The online survey was opened on 3 December 2014 
and a link to the survey was emailed to national and 
European societies for cardiology and stroke medicine, 
along with a cover letter providing additional 
information. The survey link was included in the 
electronic newsletters of the European Society of 
Cardiology, the European Stroke Organisation and the 
AF Association. In order to maximise the response 
rate, national cardiac and stroke societies affiliated with 
the above European organisations were emailed 
directly (59 and 31 societies, respectively). A reminder 
email was sent in March 2015. Positive responses were 
received from the following national societies 
confirming the distribution of the survey to clinicians 
within their organisation: Danish Stroke Society, Italian 
Stroke Organization, Swedish Society of Cardiology, 
Israel Working Group on Cardiac Pacing and 
Electrophysiology of the Israel Heart Society, Belgian 
Heart Rhythm Association, and Belgian Society of 
Cardiology. The survey was closed on 1 May 2015. 
Ethical approval for the survery study was granted 
from the Ethics Committee of the Medical, Veterinary 
and Life Sciences College, University of Glasgow, UK.
Data analysis
The results of the completed online survey were 
downloaded and descriptive statistics were produced 
for each question. Pearson Chi-Squared analysis was 
used for categorical data. Odds ratios (OR) were 
calculated using binary logistic regression. Reported OR 
and the associated 95% confidence intervals (95% CI) 
expressed the odds of respondents giving a specified 
answer based on their specialty, with respondents who 
expressed a dual interest in ‘both stroke medicine and 
cardiology’ being excluded from analyses. The 
concordance for the decision to start oral anticoagulant 
treatment (based on eight hypothetical cases) between 
clinicians in stroke versus cardiology specialties was 
quantified by Cohen’s kappa coefficients.8 In view of 
unequal numbers in the two specialties, a sample of 
individuals from the larger specialty were selected at 
random to produce comparable pairs to test the 
agreement, with individual answers from the eight 
hypothetical scenarios being analysed sequentially. 
Analyses were undertaken using IBM SPSS (V22.0, New 
York), SAS version 9.3 (SAS Institute, Inc., Cary, NC, 
USA) and Microsoft Excel 2011 (Microsoft, USA). 
ReSUlTS
Demographics
A total of 311 clinicians completed the survey, of whom 
223 (72%) had a special interest in stroke medicine, 52 
(17%) in cardiology and 36 (12%) in both stroke 
medicine and cardiology. The majority of responders, 
265 (85%), had completed specialty training. Responders 
came from 32 countries across Europe. The three 
countries that contributed the most responses were 
Germany 74 (24%), UK 46 (15%) and Turkey 44 (14%).
Electrocardiographic diagnosis of AF
A total of 250 (80%) stated that they would accept a 
single 12-lead ECG showing features consistent with 
AF as sufficient evidence to support a diagnosis. When 
using ambulatory monitoring, 111 (36%) would accept 
an episode of ‘atrial arrhythmia without p waves and 
with irregular ventricular response’ lasting less than 
30 seconds to support a diagnosis of AF.  This rose to 
188 (61%) if multiple episodes of under 30 seconds’ 
duration were detected. The minimum duration of a 
single episode to support a diagnosis varied widely, 
with 64 (21%) accepting an episode of 1–10 seconds 
on ambulatory monitoring, while 17 (6%) demanded 
greater than 2 minutes to meet their diagnostic 
threshold. Stroke physicians were twice as likely as 
cardiologists to accept < 30 seconds of atrial 
arrhythmia as being sufficient to diagnose AF (OR 2.4, 
95% CI 1.2—5.0).
RT Tran, AJ Rankin, AH Abdul-Rahim et al.
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In the event that 24 hour ambulatory ECG monitoring 
revealed an episode of possible AF but the duration 
was too short to meet the responder’s diagnostic 
threshold, the majority (175;  56%) would arrange 
longer ambulatory monitoring.
Screening for AF after ischaemic stroke or TIA
The most commonly reported method for screening 
for AF following ischaemic stroke or transient 
ischaemic attack (TIA) was ambulatory ECG, as 
shown in Figure 1. Table 1 shows the most popular 
method reported by country.
The use of implantable loop recorders for the 
investigation of suspected AF
A total of 278 (89%) advocated the use of implantable 
loop recorders (ILR) for investigation of suspected AF in 
selected patients, but only half of the responders were 
currently using implantable devices in clinical practice. A 
third stated that the resource was not available. The 
remaining responders would not use ILRs in this setting 
based on clinical grounds (Figure 2). The use of ILRs 
varied by country (Table 1). In comparison to cardiologists, 
stroke physicians were 2.6 times more likely to advocate 
the use of ILRs on clinical grounds for the detection of 
AF in selected patients (OR 2.6, 95% CI 1.1–5.9).
Decision to start anticoagulant treatment as stroke 
prevention
With regards to the decision to start anticoagulant 
treatment, 132 (42%) said the duration of atrial 
arrhythmia detected on ambulatory monitoring would 
affect their decision. Figure 3 shows the response rates 
for the decision to commence anticoagulant treatment 
in eight hypothetical clinical settings. Overall, there was 
a mean agreement of responses of 77% across the eight 
clinical scenarios. 
When comparing the decision of starting oral 
anticoagulant treatment by cardiologists and stroke 
physicians across the eight clinical scenarios, there was a 
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FiguRe 1 Current methods for screening for AF following 
ischaemic stroke/TIA
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‘fair agreement’ in responses (Kappa = 0.38 (95% CI 
0.29–0.47); p <0.001). For six of the eight hypothetical 
patients there was no difference between the two 
specialties. However, stroke physicians were more likely 
to advocate long-term anticoagulation for two of the 
lower risk patient examples. Stroke physicians were 
almost three times more likely to initiate oral anticoagulants 
for a male patient with a CHA2DS2-VASc score of 1, if they 
had multiple short episodes of arrhythmia on ambulatory 
monitoring (OR 2.7, 95% CI 1.3–5.7). Stroke physicians 
were also twice as likely to start anticoagulant treatment 
for a patient with a CHA2DS2-VASc score of 2 but with no 
previous stroke, if their ambulatory monitoring showed a 
single episode of atrial arrhythmia lasting < 30 seconds 
(OR 1.9, 95% CI 1.0–3.5). 
DISCUSSION
The results of this European-wide survey highlight the 
clinical dilemma faced by stroke physicians and 
cardiologists with regards to investigation and management 
of patients with short runs of atrial arrhythmia. 
These results mirror those of a recent survey among 
physicians in the UK, which found a lack of consensus on 
diagnosis and management of this subgroup of patients.7 
In comparison to the previously reported UK cohort, 
diagnostic thresholds were similar: 80.4% would accept 
a single 12-lead ECG as diagnostic of AF whereas only 
35.7% would accept a single run of atrial arrhythmia 
resembling AF lasting < 30 seconds. The corresponding 
figures from the UK-wide survey were 87.3% and 44.8%, 
respectively. However, within the European cohort there 
were significant differences between stroke physicians 
and cardiologists that were not detected in our previous 
survey.7 For instance, stroke physicians were twice as 
likely to accept a run of arrhythmia lasting < 30 seconds 
as diagnostic of AF, and were also more likely to advocate 
a long-term oral anticoagulant for some lower risk 
patient categories. The current survey also adds 
information regarding the views and utilisation of ILRs to 
screen for AF, with the majority (89.4%) of responders 
supporting their use on clinical grounds, but far fewer 
(50.2%) using them in current clinical practice due to 
resource constraints.
Country n % stroke 
physicians
% who 
accept 
12-lead eCg
% who 
accept 
< 30 seconds 
on 
ambulatory 
monitoring
Most common 
method used 
to screen for 
AF post-stroke
% who 
currently 
use iLR for 
detection of 
possible AF 
post-stroke
Germany 73 85 84 49 24-hr Holter 95
UK 45 58 71 38 24-hr Holter 27
Turkey 44 98 68 46 24-hr Holter 21
Belgium 26 39 85 31 24-hr Holter 62
Denmark 14 50 100 14 Inpatient
continuous 
monitoring/72-hr 
Holter
57
Italy 12 92 67 25 Inpatient
continuous 
monitoring
67
Hungary 10 10 90 30 24-hr Holter 30
Poland 9 0 100 22 24-hr Holter 11
Switzerland 8 100 75 25 7-day Holter 50
Portugal 7 100 86 29 24-hr Holter 57
Spain 7 71 86 14 Inpatient
continuous 
monitoring
29
Slovenia 6 83 83 33 24-hr Holter 33
Netherlands 5 80 100 60 24-hr Holter 40
Finland 5 80 80 40 24-hr Holter 40
Other (< 5 responses)* 40 78 83 20 24-hr Holter 35
*Other countries include: Albania, Australia, Austria, Belgium, Bulgaria, Costa Rica, Estonia, France, Georgia, Greece, Indonesia, 
Israel, Latvia, Luxembourg, Norway, Philippines, Republic of Ireland, Romania, Russia, Serbia, Sweden, Ukraine, USA, United Arab 
Emirates
tAbLe 1 Results by country
RT Tran, AJ Rankin, AH Abdul-Rahim et al.
J R Coll Physicians Edinb 2016; 46: 87–92
© 2016 RCPE
91
clinical
J R Coll Physicians Edinb 2016; 46: 87–92
© 2016 RCPE
The results of this survey are produced at a time when 
there is much debate surrounding the clinical importance 
of both the frequency and duration (i.e. burden) of atrial 
arrhythmia episodes with regards to stroke risk. Some 
data suggest a positive relationship between increasing 
AF burden and risk of thromboembolic stroke.9,10 
Conversely, data from recent trials suggest a poor 
temporal relationship between AF and stroke.11–13 In a 
subgroup analysis of data extracted from the TRENDS 
study,  only 27.5% of participants who went on to 
develop an ischaemic stroke had had an episode of AF 
within a month prior to suffering a stroke;11 the 
corresponding figure from the ASSERT trial was 15.4%.12 
However, both these studies required participants to 
have an atrial arrhythmia lasting a minimum of 5 minutes 
to be included in the primary analysis.10,11 The question 
remains as to whether there exists a closer temporal 
relationship of stroke with shorter runs of atrial 
arrhythmia. Runs of AF lasting < 30 seconds are thought 
to predispose to AF and contribute to stroke risk.5,6,14,15 
A recent systematic review and meta-analysis has shown 
that these brief paroxysms are also common in the early 
days post-stroke.16 Therefore, it may be that the studies 
that require longer periods of AF for inclusion do not 
give an accurate representation of the relationship 
between AF burden and stroke risk.
The minimum duration of AF used within trials is often 
based on technical failings of detection algorithms rather 
than on scientific grounds. Indeed, these failings are a 
major factor in the choice of the 30 second threshold 
that the European Society of Cardiology advises for 
ECG diagnosis of AF.  The algorithms used by automated 
detection mechanisms demand a minimum number of 
R-R intervals to assess variability with enough confidence 
to deliver a diagnosis of AF.  Thus, the threshold depends 
on a low sensitivity test; a new, higher sensitivity 
approach may prompt different guidance.
While use of implantable recording devices to detect AF 
post-cryptogenic stroke offer the most comprehensive 
means of detection, they are invasive and, as the results of 
this survey have shown, prohibitively expensive in some 
countries. Randomised trials are currently examining the 
use of non-vitamin K antagonist oral anticoagulants versus 
antiplatelet therapy as a potential alternative to exhaustive 
AF screening.17,18 These studies assume that many 
cryptogenic strokes are embolic in nature and therefore 
potentially justify treatment. While the treatment effect of 
anticoagulants for patients in sinus rhythm is not known, 
positive outcomes in these trials may reduce the need for 
expensive and invasive monitoring. However, it may be 
more cost-effective and ethically justifiable to perform 
more rigorous screening for AF.
The majority of respondents to this survey accepted a 
single 12-lead ECG as diagnostic of AF – the assumption 
being that in order for such a finding to be revealed on 
a 10 second recording, the abnormal rhythm is likely to 
be present more permanently. Extrapolating this 
further, it is not unreasonable to assume that, if a short 
run of AF is picked up on a 24-hour Holter monitor, 
longer paroxysms may be present outwith the 
monitored period. Indeed, a number of recent clinical 
trials using advanced technology to detect AF have 
demonstrated that the prevalence of AF post-
cryptogenic stroke is significantly higher than previously 
thought, and in particular that longer periods of 
monitoring significantly increase the diagnostic yield of 
AF.19–21 Current clinical practice seems to be aligned 
with this evidence, as demonstrated by 56% of 
responders choosing to arrange longer ambulatory 
monitoring if initial 24-hour monitoring is suggestive, 
but not diagnostic of AF. However, with the pick-up rate 
for 24-hour Holter monitoring being as low as 3.2% at 
30 days,20 the rationale behind guidelines recommending 
24-hour monitoring as a first line screening tool, as 
selected by 47% of respondents to the current survey, 
is called into question. There is a suggestion that it may 
be sensible for guidelines to recommend a longer 
minimum period (e.g. 72-hour or 7-days) of monitoring 
as the standard approach.
This survey highlights that the clinical dilemma faced by 
physicians is not unique to the UK. It included a larger 
number of physicians across a wider geographical area 
than the previous survey, and reiterates the need for 
further trial evidence in this area. This study has a 
number of limitations, some of which are inherent to 
the online survey approach.7 Despite the survey being 
sent to many national and international stroke and 
cardiology societies, the response rate was low, with 
small numbers from many countries, and no responses 
from others. We are not able to provide a definitive 
number of non-responders, but acknowledge that given 
the size of the societies contacted, this number is likely 
to be large. Over half (53%) of the responses came 
from three countries. The results, therefore, are not 
necessarily applicable to Europe as a whole, neither are 
they necessarily representative of the populations of 
stroke or cardiology doctors in their respective 
countries. A greater proportion of responders (72%) 
were stroke physicians, who encounter this problem 
daily and see the consequences of incorrect decisions. 
Stroke physicians are also more likely to see patients 
with AF for secondary prevention of stroke, whereas 
cardiologists commonly manage patients with AF in the 
lower risk setting of primary prevention. This difference 
in risk profile between the two populations of patients 
could explain the differences in attitudes between the 
two specialties. The degree of investigation required to 
satisfy clinicians that ‘no cause had been identified’ for 
a recent TIA/ischaemic stroke is likely to vary between 
centres. We specifically avoided a prescriptive approach 
on what would be sufficient evidence to call a stroke 
cryptogenic to allow assessment of the responders’ 
Short runs of atrial arrhythmia and stroke risk
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In conclusion, short runs of AF create a clinical dilemma 
for physicians across Europe. There is significant variation 
between cardiologists and stroke physicians with regards 
the diagnosis and management of patients with short 
runs of atrial arrhythmia, meaning that the same patient 
will be treated differently depending on which specialist 
that they see. The exact relationship between short runs 
of AF and stroke risk remains unknown and further 
research is required to allow guideline development for 
this clinically important population who are presently 
deprived of optimal thromboprophylaxis. 
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